Costs of Single Maintenance and Reliever Therapy vs Traditional Therapy for Asthma

Does guideline-recommended single maintenance and reliever therapy (SMART) for asthma cost less than traditional therapy for US health care payers?In this economic evaluation using a decision-tree model and Monte Carlo simulation approach and including data from 11 988 participants, SMART was less costly than traditional therapy for US health care payers.The findings of this study suggest that expanding coverage of SMART could provide financial benefits to health care payers.

Corresponding Author: James G. Krings, MD, MSc, Division of Pulmonary and Critical Care Medicine, Washington University in St Louis School of Medicine, 660 S Euclid Ave, MSC 8052-43-14, St Louis, MO 63110 (kringsj@wustl.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.